Granulocyte-Macrophage Colony-Stimulating Factor Expressed by Recombinant Respiratory Syncytial Virus Attenuates Viral Replication and Increases the Level of Pulmonary Antigen-Presenting Cells

An obstacle to developing a vaccine against human respiratory syncytial virus (RSV) is that natural infection typically does not confer solid immunity to reinfection. To investigate methods to augment the immune response, recombinant RSV (rRSV) was constructed that expresses murine granulocyte-macro...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Bukreyev, Alexander, Belyakov, Igor M., Berzofsky, Jay A., Murphy, Brian R., Collins, Peter L.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2001
Matèries:	Vaccines and Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC116109/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11711604/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.24.12128-12140.2001
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!